BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IM-1617 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IM-1617\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07578571-2539@assetmemo.bio
DTSTAMP:20261121T005453Z
DTSTART;VALUE=DATE:20290131
DTEND;VALUE=DATE:20290201
SUMMARY:IM-1617: Phase 1 readout est. (NCT07578571)
DESCRIPTION:IM-1617\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Phase
  1 Study of IM-1617 in Participants With Advanced Cancer\nEstimated primar
 y completion: January 2029. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/im-1617#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07578571
URL:https://assetmemo.bio/drug/im-1617#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
